Status:
RECRUITING
A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care
Lead Sponsor:
Lee Anne Siegmund
Conditions:
Heart Failure
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complica...
Detailed Description
Research question: Are the methods used in a pilot study that is designed to implement a nurse-led daily weight monitoring intervention, appropriate for a larger study to be conducted later, which wil...
Eligibility Criteria
Inclusion
- Adults (55 years or older)
- New or existing diagnosis of HF (regardless of type or length of time since diagnosis).
- Being treated for HF signs and/or symptoms during the current hospitalization (any of the following: IV diuretic, fluid restriction, low sodium diet).
- Must be able to read and communicate in English.
- Must be able to stand and weigh independently.
- Must have a scale at home, or ability to obtain one for the study.
Exclusion
- Documented diagnosis of cognitive impairment.
- A Charlson Comorbidity Index (CCI) of \>4. This was chosen to exclude patients more likely to have hospital stays longer than a week. A CCI of \>3 was based on research showing a relationship to mortality (Imam et al., 2020), a CCI of ≥ 6 with a 2.8-times higher mortality (Yilmaz \& Omurlu, 2019), and likelihood of longer hospital length of stay for patients with HF if CCI \>2 (Foraker et al., 2014).
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT07184541
Start Date
November 1 2024
End Date
December 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Avon Hospital
Avon, Ohio, United States, 44011